|
|
2 Registered suppliers
Description : GSK-2018682 is a potent and selective agonist of sphingosine-1-phosphate receptor (S1PR) subtype 1 that has the potential to treat multiple sclerosis (MS). - Molecular Weight :440.884
- Purity :≥98%
Molecular Formula : C22H21ClN4O4 Canonical SMILES : CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl InChI : InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29) InChIKey : NFIGDBFIDKDNIG-UHFFFAOYSA-N Solubility : Soluble in DMSO Appearance : Solid powder Synonyms : GSK2018682; GSK 2018682; GSK-2018682. UNII-NJL503AIJA; NJL503AIJA; 4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid
More details are to be found here
Detailed information on the suppliers of
GSK2018682
|
Properties:
... more properties and specification on GSK2018682
|
|
Privileged suppliers
Last update 2024-05-03
|